Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 38
Filter
1.
Cancer Cell ; 31(6): 771-789.e6, 2017 06 12.
Article in English | MEDLINE | ID: mdl-28609656

ABSTRACT

Intrahepatic cholangiocarcinoma (ICC) is a highly malignant, heterogeneous cancer with poor treatment options. We found that mitochondrial dysfunction and oxidative stress trigger a niche favoring cholangiocellular overgrowth and tumorigenesis. Liver damage, reactive oxygen species (ROS) and paracrine tumor necrosis factor (Tnf) from Kupffer cells caused JNK-mediated cholangiocellular proliferation and oncogenic transformation. Anti-oxidant treatment, Kupffer cell depletion, Tnfr1 deletion, or JNK inhibition reduced cholangiocellular pre-neoplastic lesions. Liver-specific JNK1/2 deletion led to tumor reduction and enhanced survival in Akt/Notch- or p53/Kras-induced ICC models. In human ICC, high Tnf expression near ICC lesions, cholangiocellular JNK-phosphorylation, and ROS accumulation in surrounding hepatocytes are present. Thus, Kupffer cell-derived Tnf favors cholangiocellular proliferation/differentiation and carcinogenesis. Targeting the ROS/Tnf/JNK axis may provide opportunities for ICC therapy.


Subject(s)
Bile Duct Neoplasms/metabolism , Cholangiocarcinoma/metabolism , Kupffer Cells/metabolism , MAP Kinase Signaling System , Tumor Necrosis Factor-alpha/metabolism , Animals , Bile Duct Neoplasms/pathology , Butylated Hydroxyanisole/therapeutic use , Carcinogenesis , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Transformation, Neoplastic/drug effects , Cholangiocarcinoma/pathology , Humans , Kupffer Cells/drug effects , Liver/drug effects , Liver/pathology , Mice , Mitochondria/drug effects , Mitochondria/metabolism , Mitochondria/physiology , Oxidative Stress/drug effects , Reactive Oxygen Species/metabolism , Receptors, Tumor Necrosis Factor/genetics , Receptors, Tumor Necrosis Factor/metabolism , Signal Transduction , Tumor Microenvironment
2.
J Toxicol Sci ; 40(4): 509-21, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26165648

ABSTRACT

We previously reported that hepatic necrosis induced by thioacetamide (TA), a hepatotoxicant, was attenuated in mice fed a high-fat diet (HFD mice) in comparison with mice fed a normal rodent diet (ND mice). In this study, we focused on investigation of the mechanism of the attenuation. Hepatic content of thiobarbituric acid reactive substances (TBARS), an oxidative stress marker, significantly increased in ND mice at 24 and 48 hr after TA administration in comparison to that in vehicle-treated ND mice. At these time points, severe hepatic necrosis was observed in ND mice. Treatment with an established antioxidant, butylated hydroxyanisole, attenuated the TA-induced hepatic necrosis in ND mice. In contrast, in HFD mice, hepatic TBARS content did not increase, and hepatic necrosis was attenuated in comparison with ND mice at 24 and 48 hr after TA dosing. Metabolomics analysis regarding hepatic glutathione, a biological antioxidant, revealed decreased glutathione and changes in the amount of glutathione metabolism-related metabolites, such as increased ophtalmate and decreased cysteine, and this indicated activation of glutathione synthesis and usage in HFD mice. Finally, after treatment with L-buthionine-S,R-sulfoxinine, an inhibitor of glutathione synthesis, TA-induced hepatic necrosis was enhanced and hepatic TBARS contents increased after TA dosing in HFD mice. These results suggested that activated synthesis and usage of hepatic GSH, which suppresses hepatic oxidative stress, is one of the factors that attenuate TA-induced hepatic necrosis in HFD mice.


Subject(s)
Antioxidants/metabolism , Diet, High-Fat , Glutathione/metabolism , Glutathione/physiology , Liver/metabolism , Massive Hepatic Necrosis/chemically induced , Obesity/etiology , Obesity/metabolism , Oxidative Stress , Thioacetamide/toxicity , Animals , Antioxidants/therapeutic use , Buthionine Sulfoximine/pharmacology , Butylated Hydroxyanisole/therapeutic use , Glutathione/biosynthesis , Male , Massive Hepatic Necrosis/drug therapy , Metabolomics , Mice, Inbred C57BL , Thiobarbituric Acid Reactive Substances/metabolism
3.
Gastroenterology ; 143(6): 1597-1608.e11, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22922425

ABSTRACT

BACKGROUND & AIMS: The transcription factor nuclear factor κB (NF-κB) is activated by the IκB kinase complex. The regulatory subunit of this complex, NF-κB essential modifier (NEMO or IKBKG), is a tumor suppressor. Hepatocyte-specific deletion of NEMO induces chronic liver inflammation that leads to apoptosis, oxidative stress, development of nonalcoholic steatohepatitis, and hepatocarcinogenesis. METHODS: We performed partial hepatectomies in mice with hepatocyte-specific disruption of NEMO (Nemo(Δhepa)). Some mice were fed a diet that contained the antioxidant butylated hydroxyanisole (BHA), and others were given daily intraperitoneal injections of the oxidant phenetyl isothiocyanate (PEITC). RESULTS: Nemo(Δhepa) mice had impaired liver regeneration after partial hepatectomy and 50% mortality, indicating that NEMO is required for the regenerative response. Liver cells of the mice had a strong oxidative stress response; these cells down-regulated the NF-κB-dependent antioxidant response and reduced levels of proteins that repair DNA double-strand breaks. However, the impairments to hepatocyte proliferation were compensated by a response of oval cells in Nemo(Δhepa) mice. Oval cells expressed low levels of albumin and thereby expressed normal levels of NEMO. Repopulation of the liver with oval cells that expressed NEMO reversed liver damage in Nemo(Δhepa) mice. Interestingly, these mice still developed hepatocellular carcinomas 6 months after partial hepatectomy, whereas Nemo(Δhepa) mice fed the BHA diet were protected from carcinogenesis. CONCLUSIONS: In livers of mice, expression of NEMO and activation of NF-κB are required for hepatocyte proliferation and liver regeneration. These mechanisms require control of oxidative stress and DNA integrity.


Subject(s)
Cell Proliferation , Hepatectomy , Hepatocytes/cytology , Intracellular Signaling Peptides and Proteins/physiology , Liver Regeneration/physiology , Liver/physiology , Liver/surgery , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Apoptosis/physiology , Butylated Hydroxyanisole/pharmacology , Butylated Hydroxyanisole/therapeutic use , Disease Models, Animal , Intracellular Signaling Peptides and Proteins/deficiency , Intracellular Signaling Peptides and Proteins/genetics , Liver/cytology , Liver Neoplasms, Experimental/pathology , Liver Neoplasms, Experimental/prevention & control , Liver Regeneration/drug effects , Male , Mice , Mice, Mutant Strains , NF-kappa B/physiology , Oxidative Stress/physiology , Phenotype
4.
J Chemother ; 16(2): 122-7, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15216944

ABSTRACT

We have demonstrated that green tea (Camellia sinensis) shows increased antimicrobial activity against bacteria and fungi when used in combination with butylated hydroxyanisole (BHA). Glycolic extract taken from green tea showed only limited activity against Streptococcus mutans and no activity against Candida albicans and certain strains of Escherichia coli. BHA, at non inhibitory concentrations, increased the microbicidal activity of green tea against 10(10) S. mutans (p<0.01), non-susceptible E. coli (p<0.01) and C. albicans (p<0.01). Green tea in combination with BHA reduced the hydrophobicity of S. mutans (p<0.01) and greatly inhibited (p<0.001) the formation of hyphae in C. albicans. The increased antimicrobial activity of green tea is related to an impairment of the barrier function in microorganisms and a depletion of thiol groups. The increased activity of green tea as an oral antimicrobial product is discussed.


Subject(s)
Anti-Bacterial Agents/pharmacology , Butylated Hydroxyanisole/pharmacology , Camellia sinensis , Phytotherapy , Plant Extracts/pharmacology , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Butylated Hydroxyanisole/administration & dosage , Butylated Hydroxyanisole/therapeutic use , Candida albicans/drug effects , Drug Synergism , Drug Therapy, Combination , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Humans , Microbial Sensitivity Tests , Plant Extracts/administration & dosage , Plant Extracts/therapeutic use
5.
J Autoimmun ; 22(4): 267-76, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15120750

ABSTRACT

Oxidative stress makes an important contribution to the development of autoimmune diabetes. We therefore tested the possible therapeutic value of two anti-oxidants, butylated hydroxyanisole (BHA) and pyrrolidine dithiocarbamate (PDTC), in the animal model of diabetes induced in susceptible DA rats by multiple low doses of streptozotocin (MLD-SZ, 20 mg/kg/day for 5 days). Administration of either BHA, or PDTC (50 mg/kg/day for 7 days), after finishing MLD-SZ injections, attenuated both the development of hyperglycemia and insulitis. Ex vivo analysis revealed that BHA treatment reduced the proliferation of autoreactive lymphocytes and down-regulated their adhesion to endothelium. In addition, BHA markedly attenuated the production of proinflammatory cytokines IL-1beta and TNF-alpha by both islets of pancreas and peritoneal macrophages. In parallel, macrophage release of cytotoxic oxygen and nitrogen intermediates superoxide anion (O(2)*(-)) and nitric oxide (NO*), respectively, was significantly inhibited. Finally, BHA treatment reduced intrapancreatic expression of inducible NO synthase (iNOS) and consequent production of NO* by pancreatic islets. Together, these data indicate that antioxidant agents might be a feasible therapeutic tools to interfere with development of autoimmune diabetes at multiple levels, including lymphocyte proliferation and adhesion, as well as the production of proinflammatory and cytotoxic mediators.


Subject(s)
Antioxidants/therapeutic use , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Type 1/drug therapy , Animals , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Autoimmunity/drug effects , Butylated Hydroxyanisole/therapeutic use , Diabetes Mellitus, Experimental/immunology , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/pathology , Diabetes Mellitus, Type 1/immunology , Diabetes Mellitus, Type 1/metabolism , Diabetes Mellitus, Type 1/pathology , Immunosuppressive Agents/therapeutic use , In Vitro Techniques , Interleukin-1/biosynthesis , Islets of Langerhans/drug effects , Islets of Langerhans/immunology , Islets of Langerhans/pathology , Lymphocytes/drug effects , Lymphocytes/immunology , Male , Nitric Oxide/biosynthesis , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Pyrrolidines/therapeutic use , Rats , Rats, Inbred Strains , Superoxides/metabolism , Thiocarbamates/therapeutic use , Tumor Necrosis Factor-alpha/biosynthesis
6.
Oper Dent ; 28(6): 825-9, 2003.
Article in English | MEDLINE | ID: mdl-14653300

ABSTRACT

Many studies have shown a considerable reduction in enamel bond strength of resin composite restorations when the bonding procedure is carried out immediately after bleaching. These studies claim that a certain waiting period is needed prior to restoration to reach the original bond strength values prior to bleaching. This study determined the effect of anti-oxidant applications on the bond strength values of resin composites to bleached dentin. Ninety human teeth extracted for orthodontic purposes were used in this study. The labial surface of each tooth was ground and flattened until dentin appeared. The polished surfaces were subjected to nine different treatments: 1) bleaching with gel (35% Rembrandt Virtuoso); 2) bleaching with gel + 10% sodium ascorbate (SA); 3) bleaching with gel + 10% butylhydroxyanisole (BHA); 4) bleaching with sol (35% hydrogen peroxide); 5) bleaching with sol + 10% sodium ascorbate; 6) bleaching with sol + 10% BHA; 7) bleaching with gel + immersed in artificial saliva for seven days; 8) bleaching with sol + immersed in artificial saliva for seven days; 9) no treatment. After bonding application, the resin composite in standard dimensions was applied to all specimens. The teeth were stored in distilled water at 37 degrees C for 24 hours and a universal testing machine determined their resistance to shear bond strength. The data was evaluated using ANOVA and Duncan tests. Bond strength in the bleached dentin group significantly decreased compared to the control group. On the other hand, the antioxidant treatment had a reversal effect on the bond strength to dentin. After the bleaching treatment, the 10% sodium ascorbate application was effective in reversing bond strength. In the samples where antioxidant was applied after the bleaching process, bonding strength in dentin tissue was at the same level as those teeth kept in artificial saliva for seven days.


Subject(s)
Dental Bonding , Dentin-Bonding Agents/chemistry , Dentin/ultrastructure , Tooth Bleaching , Analysis of Variance , Antioxidants/chemistry , Antioxidants/therapeutic use , Ascorbic Acid/chemistry , Ascorbic Acid/therapeutic use , Butylated Hydroxyanisole/chemistry , Butylated Hydroxyanisole/therapeutic use , Composite Resins/chemistry , Dentin/drug effects , Humans , Hydrogen Peroxide/chemistry , Hydrogen Peroxide/therapeutic use , Materials Testing , Oxidants/chemistry , Oxidants/therapeutic use , Saliva, Artificial/chemistry , Shear Strength , Stress, Mechanical , Surface Properties , Time Factors , Water/chemistry
7.
Cancer Lett ; 137(2): 123-30, 1999 Apr 01.
Article in English | MEDLINE | ID: mdl-10374832

ABSTRACT

The potential activities of butylated hydroxyanisole (BHA), myo-inositol, curcumin, esculetin, resveratrol and lycopene-enriched tomato oleoresin (LTO) as chemopreventive agents against lung tumor induction in A/J mice by the tobacco smoke carcinogens benzo[a]pyrene (BaP) and 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) were evaluated. Groups of 20 A/J mice were treated weekly by gavage with a mixture of BaP and NNK (3 micromol each) for 8 weeks, then sacrificed 26 weeks after the first carcinogen treatment. Mice treated with BHA (20 or 40 micromol) by gavage 2 h before each dose of BaP and NNK had significantly reduced lung tumor multiplicity. Treatment with BHA (20 or 40 micromol) by gavage weekly or with dietary BHA (2000 ppm), curcumin (2000 ppm) or resveratrol (500 ppm) from 1 week after carcinogen treatment until termination had no effect on lung tumor multiplicity. Treatment with dietary myo-inositol (30,000 ppm) or esculetin (2000 ppm) from 1 week after carcinogen treatment until termination significantly reduced lung tumor multiplicity, with the effect of myo-inositol being significantly greater than that of esculetin. Treatment with dietary LTO (167, 1667 or 8333 ppm) from 1 week before carcinogen treatment until termination had no effect on lung tumor multiplicity. The results of this study demonstrate that BHA is an effective inhibitor of BaP plus NNK-induced lung tumorigenesis in A/J mice when administered during the period of carcinogen treatment and that, among the compounds tested, myo-inositol is most effective after carcinogen treatment.


Subject(s)
Anticarcinogenic Agents/therapeutic use , Lung Neoplasms/prevention & control , Animals , Antioxidants/therapeutic use , Benzo(a)pyrene , Butylated Hydroxyanisole/therapeutic use , Carotenoids/therapeutic use , Curcumin/therapeutic use , Female , Inositol/therapeutic use , Lung Neoplasms/chemically induced , Lycopene , Mice , Mice, Inbred A , Nitrosamines , Resveratrol , Stilbenes/therapeutic use , Umbelliferones/therapeutic use
8.
Zhonghua Yu Fang Yi Xue Za Zhi ; 33(2): 94-7, 1999 Mar.
Article in Chinese | MEDLINE | ID: mdl-11864462

ABSTRACT

OBJECTIVE: To investigate the effects of 2(3)-tert-4-hydroxyanisole (BHA) on protection against synergistic hepatocarcinogenesis of aflatoxin B(1) (AFB(1)) and hepatitis B virus (HBV) expression in HBV large envelope transgenic mice. METHODS: Protective effects of dietary antioxidant BHA on life span was observed in 49 cases of HBV transgenic mice and 48 cases of non-transgenic mice by determinations of enzyme activities and liver MDA, and by direct detection of liver oxidative free radicals (OFR) using electron spin resonance (ESR). RESULTS: In the HBV transgenic mice which exposed to AFB1, the incidence of hepatocellular adenoma was 17% (2/12), but no carcinoma was found in BHA group. In the regular diet group, that was greater with 67% (6/9) of adenoma and 22% (2/9) of carcinoma. BHA could decrease significantly the concentrations of liver MDA and OFR, compared with those with regular diet. The activities of quinone reductase and glutathione S-transferase in liver cytosols increased by 3 - 7 times, as in the controls, in response to BHA. CONCLUSIONS: Addition of BHA to the diet resulted in significantly elevation of phase II enzyme activities in liver. BHA could directly eliminate liver OFR and inhibit growth of hepatocellular altered foci. These actions may effectively put off hepatocellular carcinogenesis in mice.


Subject(s)
Aflatoxin B1/antagonists & inhibitors , Antioxidants/pharmacology , Butylated Hydroxyanisole/pharmacology , Hepatitis B/complications , Liver Neoplasms, Experimental/prevention & control , Animals , Anticarcinogenic Agents/pharmacology , Anticarcinogenic Agents/therapeutic use , Antioxidants/therapeutic use , Biotransformation , Butylated Hydroxyanisole/therapeutic use , Carcinogens/antagonists & inhibitors , DNA, Viral/analysis , Free Radicals/analysis , Liver Neoplasms, Experimental/etiology , Male , Mice , Mice, Transgenic , Oxygen/analysis
9.
J Photochem Photobiol B ; 45(2-3): 136-43, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9868804

ABSTRACT

The effects of photodynamic therapy (PDT) alone and in combination with 3(2)-t-butyl-4-hydroxyanisole (BHA) on Ehrlich ascites carcinoma (EAC) cells have been investigated. BHA, a widely used food antioxidant, administered to the cells prior to light exposure is found to cause concentration-dependent alterations of the haematoporphyrin derivative (HpD)-based PDT. BHA (0.15 mM) causes a small (about 10%) inhibition in the rate of HpD-photosensitized injury of EAC cells. In contrast, upon increasing the concentration of BHA from 0.15 to 0.5 mM, a 1.3-fold enhancement in HpD-PDT efficiency is achieved. The cytotoxic effect on the cells treated with HpD-PDT and a higher concentration of BHA (0.5 mM) is additive. When BHA (0.5 mM) is given immediately after HpD-PDT, the combination is found to be three to four times more effective than when BHA is added to EAC cells before phototherapy. In this treatment regimen BHA acts synergistically with HpD-PDT. Such a difference in the action of BHA on the efficiency of HpD-PDT might be explained by the ability of BHA to inhibit the HpD-photosensitized destruction of some biomolecules. An enhancing action of BHA on the intensity of HpD-photosensitized death of tumour cells is also observed in vivo. Even a single dose of BHA (0.6 mM kg-1, 15 min after irradiation) causes (in an additive manner) an approximately two-fold increase in the efficiency of HpD-PDT of mice bearing Ehrlich ascites tumour (intraperitoneal transplantation). The results obtained indicate that the potentiating effect of BHA on the HpD-PDT could be caused by the impairment of the mitochondrial respiration, since there is a good correspondence between the concentration of BHA that increases the efficiency of PDT and the concentration that inhibits the oxygen consumption and dehydrogenase activity of EAC cells. The influence of BHA on the efficiency of PDT does not depend on the nature of the photosensitizer used; the effects with chlorin-e6 trimethyl ester are similar to that seen for HpD.


Subject(s)
Butylated Hydroxyanisole/therapeutic use , Carcinoma, Ehrlich Tumor/drug therapy , Photochemotherapy , Animals , Butylated Hydroxyanisole/adverse effects , Disease Models, Animal , Female , Mice
10.
Circulation ; 98(8): 794-9, 1998 Aug 25.
Article in English | MEDLINE | ID: mdl-9727550

ABSTRACT

BACKGROUND: Tumor necrosis factor-alpha (TNF-alpha) and angiotensin II (Ang II) modulate heart failure in part by provoking the hypertrophic response. Signal transduction pathways of those factors are implicated in reactive oxygen intermediates (ROIs). Therefore, we hypothesized that TNF-alpha and Ang II might cause myocyte hypertrophy via the generation of ROIs. METHODS AND RESULTS: To test the hypothesis, we tested whether TNF-alpha and Ang II could induce the generation of ROIs and whether antioxidants such as butylated hydroxyanisole (BHA), vitamin E, and catalase might inhibit the hypertrophy in cultured neonatal rat cardiac myocytes. ROIs were measured by the ROI-specific probe 2',7'-dichlorofluorescin diacetate in cultured cardiac myocytes. We demonstrated that TNF-alpha and Ang II induced the generation of ROIs in a dose-dependent manner. TNF-alpha (10 ng/mL) and Ang II (100 nmol/L) enlarged cardiac myocytes and increased [3H]leucine uptake, and BHA (10 micromol/L) significantly inhibited both effects. Other antioxidants, such as vitamin E (1 microg/mL) and catalase (100 U/mL), also inhibited the enlargement of cardiac myocytes induced by TNF-alpha. CONCLUSIONS: These results indicate that TNF-alpha and Ang II cause hypertrophy in part via the generation of ROIs in cardiac myocytes.


Subject(s)
Angiotensin II/toxicity , Antioxidants/therapeutic use , Cardiomegaly/drug therapy , Tumor Necrosis Factor-alpha/toxicity , Animals , Animals, Newborn , Butylated Hydroxyanisole/therapeutic use , Cardiomegaly/chemically induced , Catalase/therapeutic use , Cells, Cultured , Leucine/metabolism , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Recombinant Proteins/toxicity , Tritium , Vitamin E/therapeutic use
11.
Jpn J Cancer Res ; 89(11): 1113-7, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9914779

ABSTRACT

The effects of praziquantel coupled with dehydroepiandrosterone (DHEA) or butylated hydroxyanisole (BHA) administration 16 weeks subsequent to dihydroxy-di-n-propylnitrosamine (DHPN) treatment and infection with Opisthorchis viverrini (OV) on lesion development in the liver of Syrian hamsters were investigated. Animals were given 80 OV metacercariae and then two i.p. injections of DHPN (500 mg/kg body weight) 4 and 5 weeks thereafter. At week 16, groups received praziquantel (250 mg/kg, i.g.) and were placed on normal diet or diet supplemented with BHA (1%) or DHEA (0.6%) until they were killed at week 24. Histopathological assessment revealed that, whereas antihelminthic treatment alone resulted in a clear reduction in hepatocellular lesion development, effects on cholangiocellular lesions were equivocal. BHA and DHEA, in contrast, were both associated with a significant reduction in frequency of cholangiofibrosis and cholangiocellular carcinoma. The former chemical, however, increased the numbers of liver nodules while the hormone brought about a decrease as well as a shift in the phenotype of the lesions. The results thus indicate that although cholangiocellular lesion development may, unlike generation of hepatocellular nodules, be to a certain extent independent of the continued presence of parasite, it can be influenced by exogenous treatments.


Subject(s)
Anthelmintics/therapeutic use , Carcinogens/toxicity , Nitrosamines/toxicity , Opisthorchiasis/drug therapy , Opisthorchis/isolation & purification , Praziquantel/therapeutic use , Animals , Butylated Hydroxyanisole/therapeutic use , Chemoprevention , Cricetinae , Dehydroepiandrosterone/therapeutic use , Drug Evaluation, Preclinical , Drug Therapy, Combination , Male , Mesocricetus , Opisthorchiasis/pathology
12.
Cancer Lett ; 104(1): 49-53, 1996 Jun 24.
Article in English | MEDLINE | ID: mdl-8640745

ABSTRACT

The phenolic antioxidants butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) were studied for inhibition of aflatoxin B1 (AFB1) hepatocarcinogenesis in male Fischer 344 rats. The antioxidants were administered at 5, 25, or 125 ppm in AIN-76A diet for 42 weeks. Beginning with week 2, 5 micrograms/kg of AFB1 was given by intragastric instillation three times a week for 40 weeks either alone or concurrently with BHA or BHT feeding. The development of hepatocellular altered foci (HAF) induced by AFB1, as indicators of hepatocarcinogenesis, was monitored using immunohistochemical staining for the placental form of glutathione S-transferase. By 16 weeks the multiplicity of foci was 1.97/cm2 of liver area in rats given only AFB1, and this increased to 4.11/cm2 at 24 weeks and to 10.60/cm2 at 32 weeks. At the final sacrifice at 42 weeks, the multiplicity of foci was 12.90/cm2 compared to 0.75/cm2 in untreated controls. In rats given antioxidants in addition to AFB1, the high dose of BHA reduced the multiplicity to 7.72/cm2 and the high dose of BHT reduced the multiplicity to 9.35/cm2. Lower levels did not reduce foci induction. Thus, in male rats under the conditions of this experiment, the level of 125 ppm of either BHA or BHT inhibited the initiation of hepatocarcinogenesis by AFB1. The BHA effect was slightly greater than that of BHT.


Subject(s)
Aflatoxin B1/antagonists & inhibitors , Anticarcinogenic Agents/therapeutic use , Antioxidants/therapeutic use , Butylated Hydroxyanisole/therapeutic use , Butylated Hydroxytoluene/therapeutic use , Carcinogens , Liver Neoplasms, Experimental/chemically induced , Liver Neoplasms, Experimental/prevention & control , Animals , Body Weight/drug effects , Dose-Response Relationship, Drug , Food Contamination , Liver/anatomy & histology , Liver/drug effects , Male , Organ Size/drug effects , Rats , Rats, Inbred F344
13.
Arch Med Res ; 27(1): 71-5, 1996.
Article in English | MEDLINE | ID: mdl-8867371

ABSTRACT

We previously reported on the induction by vitamin A of gallstones, rich in calcium and phosphate, in hamsters. On the other hand, it has been reported that the phenolic antioxidant butylated hydroxytoluene (BHT) potentiates the hepatotoxicity of vitamin A. In the present work we have tested the effect of BHT on the lithogenicity of vitamin A and on bile composition. The urinary excretion of calcium and phosphate was determined to assess a possible asymptomatic bone resorption due to vitamin A toxicity, and/or an effect of BHT on the homeostasis of calcium and phosphate. Three groups of 18 male hamsters were fed with the following diets for 70 days: Group 1, Purina Nutricubes (DB); Group 2, DB + 25,000 IU% retinol acetate (DL); Group 3, DL + 500 mg% BHT. Vitamin A (Group 2) induced gallstones in 78% of the animals, increased bile flow and biliary phosphate and calcium concentrations, and reduced those of bile salt, cholesterol and phospholipid. BHT (Group 3) reduced gallstone frequency to 5.5%, and decreased biliary phosphate, calcium and lipids toward more normal concentrations. Vitamin A alone or with BHT did not significantly affect food intake or urinary excretion of calcium and phosphate.


Subject(s)
Bile Pigments/analysis , Butylated Hydroxyanisole/therapeutic use , Cholelithiasis/chemically induced , Cholelithiasis/prevention & control , Vitamin A/toxicity , Animals , Cholelithiasis/chemistry , Cricetinae , Male , Mesocricetus
14.
Sci China B ; 37(4): 418-29, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8068195

ABSTRACT

Tumours of mice are induced by administration of Inj. Hydroxyprogesteroni Caproatis Co. (EP) in a practical subthreshold dose of carcinogenesis or 2.5-5 times the human contraceptive dose (simply referred to as 2.5- to 5-fold dose) combined with whole-body 0.5 Gy gamma-ray irradiation. Malignant transformation of Syrian golden hamster embryo (SHE) cells is also induced by 5-fold dose of EP combined with 0.3 Gy gamma-ray irradiation in vitro, thereby indicating that synergistic carcinogenesis can be obtained by combined use of physical and chemical carcinogens. The mechanisms of synergistic carcinogenesis have been further explained by cytogenetics, damage extent of the target cell DNA and production of free radicals. The Chinese traditional medicine with antioxidating effect (Sulekang Capsule, SC), food additive--butylated hydroxyanisole (BHA) and green tea can effectively inhibit the carcinogenic effect of EP or EP combined with gamma rays in mice. They all have marked ability to scavenge or remove the free radicals and thereby reduce the DNA damage.


Subject(s)
Butylated Hydroxyanisole/therapeutic use , Drugs, Chinese Herbal/therapeutic use , Estrogen Antagonists/toxicity , Hydroxyprogesterones/toxicity , Neoplasms, Experimental/prevention & control , Tea , 17 alpha-Hydroxyprogesterone Caproate , Animals , Cell Transformation, Neoplastic , Cricetinae , Delayed-Action Preparations , Female , Male , Mesocricetus , Mice , Micronucleus Tests , Neoplasms, Experimental/chemically induced , Progesterone Congeners/toxicity
15.
Cesk Farm ; 42(6): 287-90, 1993 Dec.
Article in Slovak | MEDLINE | ID: mdl-8111863

ABSTRACT

The present paper aimed to examine a possible influence of the antioxidant butylhydroxyanisole (BHA) on the extent of atherosclerotic changes in coronary arterioles, in arcus aortae, and on the influencing of the extent of myocardial necroses. The model of atherosclerosis was worked out by administering 1% cholesterol diet to Japanese quails for the period of 40 days. The above-mentioned changes were examined on histological preparations and they were evaluated morphometrically. Quantification and morphometry of atherosclerotic changes in the individual experimental groups are shown in Table 1 and statistical evaluation of findings using the t-test in Tables 2, 3 and 4. The protective effect of butylhydroxyanisole was demonstrated to be statistically significant in the examination of the extent of atheromatous changes in arterioles. In arcus aortae, the findings were neither extensive, nor statistically significant. The findings concerning the extent of necroses in the myocardium provide documentary evidence for subendothelial micronecroses in the group with BHA in contrast to blended necroses in the group with Epavit + cholesterol. The model of cholesterol diet used in Japanese quails proved to be suitable to examine the pathogenesis of atherosclerosis and its possible influencing by pharmaceuticals. The dose of butylhydroxyanisole (BHA), 20 mg.kg-1, was selected in the optimal manner with regard to possible inhibition of atherosclerotic changes.


Subject(s)
Antioxidants/therapeutic use , Arteriosclerosis/pathology , Butylated Hydroxyanisole/therapeutic use , Animals , Arteriosclerosis/drug therapy , Coturnix
16.
Carcinogenesis ; 14(8): 1615-20, 1993 Aug.
Article in English | MEDLINE | ID: mdl-8394781

ABSTRACT

Electron paramagnetic resonance spin-trapping has been used to study the production of free radicals from tert-butyl hydroperoxide, tert-butyl peroxybenzoate, cumene hydroperoxide and ethyl hydroperoxide in isolated murine keratinocytes. Free radical species could be trapped from keratinocytes treated with all peroxides, with radicals produced from both one-electron oxidative and reductive pathways. The hindered phenolic antioxidants butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT), which are known to inhibit peroxide-induced tumour promotion in vivo, decreased the amount of radical adduct production at a concentration of 10 mM, with BHA being significantly more effective than BHT. That all the peroxides in this study produced free radicals in keratinocytes, and that BHA and BHT decreased the amounts of radicals trapped, suggests that free radical production by organic peroxide compounds is involved in their in vivo tumour-promoting activity.


Subject(s)
Antioxidants/pharmacology , Carcinogens/metabolism , Carcinogens/toxicity , Free Radicals/metabolism , Keratinocytes/drug effects , Keratinocytes/metabolism , Peroxides/metabolism , Peroxides/toxicity , Animals , Anticarcinogenic Agents/pharmacology , Anticarcinogenic Agents/therapeutic use , Antioxidants/therapeutic use , Butylated Hydroxyanisole/pharmacology , Butylated Hydroxyanisole/therapeutic use , Butylated Hydroxytoluene/pharmacology , Butylated Hydroxytoluene/therapeutic use , Electron Spin Resonance Spectroscopy , Free Radical Scavengers , Free Radicals/toxicity , Kinetics , Male , Mice , Skin Neoplasms/chemically induced , Skin Neoplasms/prevention & control , Spin Labels , tert-Butylhydroperoxide
17.
Jpn J Cancer Res ; 83(5): 431-7, 1992 May.
Article in English | MEDLINE | ID: mdl-1618695

ABSTRACT

Potential synergism between 4 antioxidants acting at low doses on development of glutathione S-transferase placental form (GST-P)-positive liver cell foci was examined in male rats initially given diethylnitrosamine (200 mg/kg, i.p.). Beginning 2 weeks after the initiation, rats received the antioxidants, individually or in combination, in the diet for 6 weeks. All rats were subjected to two-thirds partial hepatectomy at week 3 and killed at week 8. The numbers and areas of GST-P-positive foci were significantly decreased by single treatment with butylated hydroxyanisole (BHA, 1%), tert-butylhydroquinone (TBHQ, 1%) and catechol (0.8%), but not with sesamol (0.5%). Combined treatments (BHA + TBHQ, catechol + sesamol, or all 4 chemicals) at a quarter of the above dose levels resulted in decrease in numbers and areas of foci to levels less than the sums of individual inhibition data obtained with the one-quarter levels. Although these combined effects were not statistically significant in the additive model, the results indicate possible synergistic suppression of carcinogenesis by low-dose combined treatment with anti-cancer agents and the usefulness of the present protocol for this type of analysis.


Subject(s)
Antioxidants/therapeutic use , Diethylnitrosamine , Liver Neoplasms, Experimental/prevention & control , Precancerous Conditions/prevention & control , Animals , Benzodioxoles , Body Weight/drug effects , Bromodeoxyuridine/metabolism , Butylated Hydroxyanisole/therapeutic use , Catechols/therapeutic use , Dose-Response Relationship, Drug , Drug Synergism , Glutathione Transferase/analysis , Glutathione Transferase/drug effects , Hydroquinones/therapeutic use , Liver/anatomy & histology , Liver/enzymology , Liver Neoplasms, Experimental/chemically induced , Liver Neoplasms, Experimental/enzymology , Male , Organ Size/drug effects , Phenols/therapeutic use , Precancerous Conditions/chemically induced , Precancerous Conditions/enzymology , Rats , Rats, Inbred F344
18.
Carcinogenesis ; 12(12): 2311-5, 1991 Dec.
Article in English | MEDLINE | ID: mdl-1747933

ABSTRACT

Carcinogen-induced aberrant crypts (AC) of the colon are a precancerous state that leads to malignancy. The inhibition of AC formation by chemopreventive agents was evaluated in this study. Colon AC were induced by 1,2-dimethylhydrazine (DMH) in 3 weeks in CF1 mice. The cecum of the large intestine of CF1 mice did not produce more than one AC focus per animal. The effect of DMH and that of the inhibitors in this part of the large bowel were essentially similar to the vehicle control and inhibitor-only controls. The response of DMH treatment in the colorectal portion of the large bowel was found to be different from that of the cecum. The DMH treated mice had 13-17 foci per animal in three different experiments. The average number of AC per focus was greater than one in all three experiments performed. None of the inhibitor-only control animals nor the cottonseed oil vehicle control animals developed AC focus in the colorectal or the cecal part of the large bowel. The known inhibitor of colon carcinogenesis 3-butyl-4-hydroxyanisole reduced DMH-induced average AC formation by 10 and 46% at 1 and 4 mg per dose, respectively. The inhibitors 2-n-butylthiophene and phenylpropylisothiocyanate reduced DMH-induced average AC formation greater than 34 and greater than 40% respectively. The postulated inhibitor 2-n-octylthiophene, which is an eight-carbon homolog of 2-n-butylthiophene, similarly reduced DMH-induced AC formation. The known colon carcinogenesis inhibitor dehydroepiandrosterone, in contrast, has no effect. The inactivity of dehydroepiandrosterone to inhibit colon AC formation was attributed to its mechanism of inhibitory action, which differs from that of the phenol, isothiocyanate and thiophenes. The short duration that is required to produce quantifiable results suggests that the reduction of carcinogen-induced AC formation may be developed into a useful prescreening assay for potential chemopreventive agents against colon cancer.


Subject(s)
Colonic Neoplasms/prevention & control , Colorectal Neoplasms/prevention & control , Precancerous Conditions/prevention & control , 1,2-Dimethylhydrazine , Animals , Butylated Hydroxyanisole/therapeutic use , Cecum/drug effects , Cecum/pathology , Colonic Neoplasms/chemically induced , Colonic Neoplasms/pathology , Colorectal Neoplasms/chemically induced , Colorectal Neoplasms/pathology , Dimethylhydrazines , Female , Methylene Blue , Mice , Mice, Inbred Strains , Precancerous Conditions/chemically induced , Precancerous Conditions/pathology , Thiophenes/therapeutic use
19.
Endocrinology ; 127(4): 1590-5, 1990 Oct.
Article in English | MEDLINE | ID: mdl-2401227

ABSTRACT

Dietary iodine has been shown to be important in the induction of thyroiditis in susceptible chicken strains although the underlying mechanism remains unknown. Iodine may exert its effects through the formation of reactive oxidative radicals which would cause thyroidal injury and initiate infiltration. We have tested this hypothesis by examining the ability of butylated hydroxyanisole (BHA), ethoxyquin, and other antioxidants to prevent thyroiditis in Obese strain (OS) chickens, a strain that develops severe disease by 4 weeks of age. BHA, when administered from hatching until death at 5 weeks of age, reduced thyroidal infiltration and serum levels of antibodies binding thyroglobulin, T3, T4. Similar effects were observed with the antioxidant ethoxyquin. Weaker antioxidants such as vitamins C and E and beta-carotene had only slight or negligible effects on these parameters. BHA reduced thyroiditis in OS chicks killed at 3 and 5 weeks of age, but not at 8 weeks. When BHA treatment was initiated after the development of severe disease, it did not reduce thyroglobulin antibody levels. To determine the mechanism by which BHA reduces thyroiditis, studies were performed to assess the effect of BHA on thyroid function and on the immune responses to exogenous antigens. BHA had no effect on thyroid function in normal strain chickens since thyroidal radioiodine uptake and organification and serum T3 and T4 levels were unaffected. BHA did not alter immune responses to exogenous antigens such as sheep red blood cells or Brucella abortus in OS chickens. In summary, potent antioxidant drugs delayed the onset of thyroiditis when treatment was initiated before the onset of disease, suggesting that reactive oxygen intermediates are involved in the early stages of pathogenesis. However, the site of action remains unknown since they had no detectable effects on thyroid function or general immune responses.


Subject(s)
Antioxidants/therapeutic use , Obesity/complications , Thyroiditis, Autoimmune/prevention & control , Animals , Antioxidants/administration & dosage , Autoantibodies/blood , Butylated Hydroxyanisole/administration & dosage , Butylated Hydroxyanisole/pharmacology , Butylated Hydroxyanisole/therapeutic use , Chickens , Ethoxyquin/administration & dosage , Ethoxyquin/therapeutic use , Thyroglobulin/immunology , Thyroid Gland/drug effects , Thyroiditis, Autoimmune/etiology , Thyroiditis, Autoimmune/immunology , Thyroxine/immunology , Time Factors , Triiodothyronine/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...